Table 3.
Sociodemographic and cancer-related predictors of unmet supportive care needs (N = 200)
| Comprehensive care information p N (%) |
Physical effects p N (%) |
Psychological effects p N (%) |
Practical issues p N (%) |
Relationships p N (%) |
|
|---|---|---|---|---|---|
| Age | .663 | .001 | .024 | .001 | .003 |
| ≤ 55 | 21 (87.5) | 12 (50.0) | 14 (58.3) | 16 (66.7) | 11 (45.8) |
| 55–65 | 57 (79.2) | 20 (27.8) | 23 (31.9) | 30 (41.7) | 19 (26.4) |
| ≥ 66 | 83 (81.4) | 11 (10.8) | 30 (29.4) | 28 (27.5) | 15 (14,7) |
| Sex | .916 | .525 | .066 | .650 | .791 |
| Female | 54 (81.8) | 16 (24.2) | 28 (42.4) | 26 (39.4) | 16 (24.2) |
| Male | 108 (81.2) | 27 (20.3) | 39 (29.3) | 48 (36.1) | 30 (22.6) |
| Living situation | .695 | .654 | .662 | .195 | .887 |
| Married/lived with partner | 116 (80.6) | 31 (21.5) | 51 (35.4) | 58 (40.3) | 34 (23.6) |
| Single/divorced/widowed | 44 (83.0) | 13 (24.5) | 17 (32.1) | 16 (30.2) | 12 (22.6) |
| Education level (n =) | .194 | .287 | .799 | .130 | .943 |
| Without studies | 28 (87.5) | 3 (9.4) | 12 (37.5) | 11 (34.4) | 8 (25.0) |
| Primary studies | 51 (72.9) | 18 (25.7) | 22 (31.4) | 23 (32.9) | 17 (24.3) |
| Secondary studies | 35 (85.4) | 10 (24.4) | 16 (39.0) | 22 (53.7) | 10 (24.4) |
| Bachelor´s degree | 38 (84.4) | 11 (24.4) | 14 (31.1) | 15 (33.3) | 9 (20.0) |
| Employment status | .549 | .398 | .007 | .044 | .041 |
| Working outside home | 26 (81.3) | 6 (18.8) | 10 (31.3) | 11 (34.4) | 6 (18.8) |
| Unemployed | 9 (90.0) | 4 (40.0) | 8 (80.0) | 8 (80.0) | 6 (60.0) |
| Retired/on sick leave | 111 (81.6) | 31 (22.8) | 41 (30.1) | 48 (35.3) | 30 (22.1) |
| Homemaker | 11 (68.8) | 2 (12.5) | 8 (50.0) | 6 (37.5) | 3 (18.8) |
| Medical primary treatments | .243 | .001 | .495 | .433 | .294 |
| Surgery (S) | 57 (85.1) | 7 (10.4) | 19 (28.4) | 21 (31.3) | 14 (20.9) |
| S + Chemotherapy (CT) | 65 (77.4) | 19 (22.6) | 30 (35.7) | 34 (40.5) | 16 (19.0) |
| S + CT + Radiotherapy (RT) | 30 (78.9) | 18 (47.4) | 16 (42.1) | 17 (44.7) | 13 (34.2) |
| Other a | 11 (100.0) | 0 (0.0) | 3 (27.3) | 3 (27.3) | 3 (27.3) |
| Time since primary treatment | .112 | .120 | .120 | .725 | .523 |
| ≤ 12 months (RE subgroup) | 25 (92,6) | 10 (37.0) | 11 (40.7) | 12 (44.4) | 7 (25.9) |
| > 12 months- ≥ 5 years (ES subgroup) | 82 ((76,6) | 22 (20.6) | 41 (38.3) | 39 (36.4) | 27 (25.2) |
| > 5 years (LTS subgroup) | 56 (84.8) | 12 (18.2) | 16 (24.2) | 24 (36.4) | 12 (18.2) |
a “other” category groups together other primary treatment strategies that were infrequent in the study participants: chemotherapy, radiotherapy, surgery plus radiotherapy and chemotherapy plus radiotherapy